ArticleCancer medicine2024

PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.

Yasutoshi Kuboki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.